Gossamer Bio, Inc. (GOSS)
2.52
+0.07
(+2.86%)
USD |
NASDAQ |
Jan 16, 16:00
2.60
+0.08
(+3.17%)
After-Hours: 20:00
Gossamer Bio SG&A Expense (TTM): 36.12M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 715.08M |
| XOMA Royalty Corp. | 32.68M |
| Rezolute, Inc. | 20.85M |
| Axsome Therapeutics, Inc. | 514.57M |
| Crinetics Pharmaceuticals, Inc. | 165.81M |